Despite significant advances in the treatment of cerebrovascular diseases that have been achieved due to the implementation of the stroke control program, mortality and disability rates in this pathology continue to be high. The use of high-tech methods for the treatment of cerebral stroke (intravenous thrombolysis) allows achieving better results in the immediate and long-term period of a cerebral stroke, however, in some cases, it is associated with significant risks. Identification of biochemical markers of an unfavorable clinical course of cerebral infarction is quite important, as it can be a useful addition to optimizing the prediction of outcomes of acute cerebrovascular accident and the effectiveness of thrombolytic therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.